Concepedia

Joern Kraetzschmar

JK

5

Publications

322

Citations

5

H-Index

2005

Active since

Affiliations

Bayer (United States)(Current)

Bayer (Germany)

Joern Kraetzschmar is an author at Bayer (United States) specializing in cancer therapeutics, cancer research, and urology.

Top concepts

Publications per year

2005–2016

5

Publications

5

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Johannes Nagelschmitz, Martin Blunck, Joern Kraetzschmar et al. · Clinical Pharmacology Advances and Applications · 2014 · 126 citations · Full text

Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators

Stewart Leung, April Holbrook, Beverly King et al. · SLAS DISCOVERY · 2005 · 97 citations · Full text

Phase I Dose Escalation Study of Telatinib, a Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor 2 and 3, Platelet-Derived Growth Factor Receptor β, and c-Kit, in Patients With Advanced or Metastatic Solid Tumors

Ferry A.L.M. Eskens, Neeltje Steeghs, Jaap Verweij et al. · Journal of Clinical Oncology · 2009 · 45 citations · Full text

Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial

Marcus‐Hillert Schultze‐Mosgau, K. Waellnitz, R. Nave et al. · Human Reproduction · 2016 · 31 citations · Full text

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

Dirk Strumberg, Beate Schultheis, Irenäus A. Adamietz et al. · British Journal of Cancer · 2008 · 23 citations · Full text

, , +17

Rows per page

1–5 of 5